MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

October 2003


A Comparison of Two Macrolide Antibiotics in the Treatment of Community-Acquired Infections

The authors conducted a retrospective study of failure rates and performed a cost-minimization analysis of azithromycin and clarithromycin.
Kavita Parmar-Lapasia, PharmD, Steven P. Gelone, PharmD, Michael R. Jacobs, PharmD, and Albert I. Wertheimer, PhD, MBA


The Changing Role of the Infectious Disease Specialist: A Conversation with Timothy Babinchak, MD

Dr. Babinchak talks about the unexpected turns during his career in the field of infectious diseases.
Sonja Sherritze

Principles of Antibiotic Formulary Selection for P&T Committees, Part 5: The Cost of Antimicrobial Therapy

Dr. Cunha describes some of the cost factors that P&T committees should consider when selecting antibiotics.
Burke A. Cunha, MD

Integrative Medicine in Pharmacy and Therapeutics

Dr. Micozzi provides an overview of the changes taking place in traditional medicine and the new roles of “alternative,” “complementary,” and “holistic” healing practices.
Marc S. Micozzi, MD, PhD

Pharmaceutical-Approval Update: Oncology

Dr. Goldenberg reviews bortezomib for injection (Velcade™) for multiple myeloma, gefitinib (Iressa™) for non-small cell lung cancer, and Bexxar® for non-Hodgkin’s lymphoma.
Marvin M. Goldenberg, PhD, RPh, MS



The AMCP’s Drug Dossier Format

David Nash, MD, MBA, discusses the AMCP’s drug dossier format.
David B. Nash, MD, MBA

Prescription Washington

Card Games: Shuffling Ideas to Create a Medicare Discount Drug Card

Stephen Barlas discusses Congressional efforts to create a Medicare discount drug card.
Stephen Barlas

Medication Errors

Reducing Medication Errors Associated with Intravenous Insulin Infusions

Matthew Grissinger explains the potential for errors with intravenous insulin infusions.
Matthew Grissinger, RPh, FASCP

Drug News

New Drugs/Drug News

P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.

Drug Forecast

Gefitinib: The First in a New Class of Agents for Non-Small Cell Lung Cancer

Drs. Ruffin and Harris review gefitinib (Iressa™), a new agent for the treatment of non-small cell lung cancer.
Charnelda G. Ruffin, PharmD, and Kathryn L. Harris, PharmD, MSHCM